2-aminopyrimidine has been researched along with Protein Aggregation, Pathological in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, HJ; Aso, K; Berk-Rauch, HE; Foley, MA; Kawasaki, M; Nishida, G; Norris, EH; Singh, PK; Strickland, S; Yamasaki, T | 1 |
1 other study(ies) available for 2-aminopyrimidine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Drug Design; Fibrinogen; Humans; Peptide Fragments; Protein Aggregates; Protein Aggregation, Pathological; Protein Interaction Maps; Pyrimidines | 2018 |